21.
Improved pregnancy outcomes in women with type 1 and type 2 diabetes but substantial clinic-to-clinic variations: a prospective nationwide study
by Murphy, Helen R
Diabetologia, 2017-06-08, Vol.60 (9), p.1668-1677
22.
Diabetes Complications Severity Index (DCSI) – Update and ICD-10 Translation
by Glasheen, William P
Journal of diabetes and its complications, 2017, Vol.31 (6), p.1007-1013
23.
Diabetes and pregnancy: national trends over a 15 year period
by Mackin, Sharon T
Diabetologia, 2018-01-11, Vol.61 (5), p.1081-1088
24.
Diabetes in Asia
by Ramachandran, Ambady, Dr
The Lancet (British edition), 2010, Vol.375 (9712), p.408-418
25.
Efficacy of cholesterol-lowering therapy in 18 686 people with diabetes in 14 randomised trials of statins: a meta-analysis
by Kearney, P M
The Lancet (British edition), 2008, Vol.371 (9607), p.117-125
26.
Mitochondrial dysfunction in diabetes: from molecular mechanisms to functional significance and therapeutic opportunities
by Sivitz, William I
Antioxidants & redox signaling, 2010-04, Vol.12 (4), p.537-577
27.
Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
by Armstrong, Matthew James, PhD
The Lancet (British edition), 2016, Vol.387 (10019), p.679-690
28.
Effect of Low-Dose Perindopril/Indapamide on Albuminuria in Diabetes: Preterax in Albuminuria Regression: PREMIER
by Mogensen, Carl Erik
Hypertension (Dallas, Tex. 1979), 2003-05, Vol.41 (5), p.1063-1071
29.
Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes
by Zoungas, Sophia
Diabetologia, 2014-09-17, Vol.57 (12), p.2465-2474
30.
Using human genetics to understand the disease impacts of testosterone in men and women
by Ruth, Katherine S
Nature medicine, 2020-02, Vol.26 (2), p.252-258
31.
Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study
by Hemkens, L. G
Diabetologia, 2009-06-30, Vol.52 (9), p.1732-1744
32.
The Maastricht Study: an extensive phenotyping study on determinants of type 2 diabetes, its complications and its comorbidities
by Schram, M.T
European journal of epidemiology, 2014-01-01, Vol.29 (6), p.439-451
33.
Multimorbidity is associated with increased rates of depression in patients hospitalized with diabetes mellitus in the United States
by Chima, Charles C.
Journal of diabetes and its complications, 2017-11, Vol.31 (11), p.1571-1579
34.
Insulin resistance in type 1 diabetes: what is ‘double diabetes’ and what are the risks?
by Cleland, S. J
Diabetologia, 2013-04-24, Vol.56 (7), p.1462-1470
35.
High Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels
by Portillo-Sanchez, Paola
The journal of clinical endocrinology and metabolism, 2015-06, Vol.100 (6), p.2231-2238
36.
Inflammation and metabolic disorders
by Hotamisligil, Gökhan S
Nature, 2006-12-14, Vol.444 (7121), p.860-867
37.
Type 2 diabetes mellitus, brain atrophy and cognitive decline in older people: a longitudinal study
by Callisaya, Michele L
Diabetologia, 2018-12-13, Vol.62 (3), p.448-458
38.
Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials
by Ray, Kausik K, Dr
The Lancet (British edition), 2009, Vol.373 (9677), p.1765-1772
39.
Long-term exposure to ambient fine particulate matter (PM2.5) and incident type 2 diabetes: a longitudinal cohort study
by Lao, Xiang Qian
Diabetologia, 2019-01-31, Vol.62 (5), p.759-769
40.
The association of depressive symptoms and diabetes distress with glycaemic control and diabetes complications over 2 years in newly diagnosed type 2 diabetes: a prospective cohort...
by Ismail, Khalida
Diabetologia, 2017-08-03, Vol.60 (10), p.2092-2102
